You just read:

Long-Term Treatment With Reminyl(R) (galantamine) may be Associated With a Reduced Risk of Institutionalisation in Patients With Dementia

News provided by

Shire Pharmaceuticals Group plc

09 Nov, 2004, 18:05 GMT